Cargando…
Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy
BACKGROUND: Surgery and radiotherapy are current therapeutic options for malignant tumors involving the nasal vestibule. Depending on the location, organ-preserving resection is not always possible, even for small tumors. Definitive radiotherapy is an alternative as an organ-preserving procedure. Ca...
Autores principales: | Eberle, Fabian, Engenhart-Cabillic, Rita, Schymalla, Markus M., Dumke, Christoph, Schötz, Ulrike, Subtil, Florentine S.B., Baumann, Kilian-Simon, Stuck, Boris A., Langer, Christine, Jensen, Alexandra D., Hauswald, Henrik, Lautenschläger, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886023/ https://www.ncbi.nlm.nih.gov/pubmed/35242709 http://dx.doi.org/10.3389/fonc.2022.814082 |
Ejemplares similares
-
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
por: Lautenschlaeger, F. S., et al.
Publicado: (2021) -
Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy
por: Dumke, R., et al.
Publicado: (2022) -
Dual PI3K/mTOR Inhibitor NVP-BEZ235 Leads to a Synergistic Enhancement of Cisplatin and Radiation in Both HPV-Negative and -Positive HNSCC Cell Lines
por: Subtil, Florentine S. B., et al.
Publicado: (2022) -
IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement
por: Tiwari, Dinesh Kumar, et al.
Publicado: (2022) -
Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining
por: Schötz, Ulrike, et al.
Publicado: (2020)